| Primary Diagnosis | Year | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | |
| Total | 2,277 | 2,429 | 2,484 | 2,417 | 2,281 | 2,315 | 2,163 | 1,052 | 1,031 | 1,005 |
| Emphysema/COPD | 751 | 855 | 821 | 733 | 727 | 716 | 675 | 369 | 370 | 388 |
| Cystic Fibrosis | 429 | 443 | 445 | 430 | 371 | 369 | 339 | 165 | 156 | 143 |
| Idiopathic Pulmonary Fibrosis | 281 | 294 | 355 | 379 | 373 | 463 | 394 | 126 | 150 | 157 |
| Alpha-1-Antitrypsin Deficiency | 164 | 159 | 162 | 151 | 140 | 130 | 100 | 74 | 58 | 53 |
| Primary Pulmonary Hypertension | 221 | 227 | 235 | 233 | 180 | 184 | 160 | 74 | 51 | 39 |
| Retransplant/Graft Failure | 52 | 60 | 54 | 62 | 58 | 54 | 64 | 25 | 43 | 33 |
| Congenital Disease | 49 | 47 | 57 | 58 | 51 | 34 | 26 | 13 | 15 | 8 |
| Other | 271 | 291 | 326 | 340 | 344 | 323 | 317 | 145 | 138 | 125 |
| Unknown | 59 | 53 | 29 | 31 | 37 | 42 | 88 | 61 | 50 | 59 |
| Total (%) | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Emphysema/COPD | 33.0% | 35.2% | 33.1% | 30.3% | 31.9% | 30.9% | 31.2% | 35.1% | 35.9% | 38.6% |
| Cystic Fibrosis | 18.8% | 18.2% | 17.9% | 17.8% | 16.3% | 15.9% | 15.7% | 15.7% | 15.1% | 14.2% |
| Idiopathic Pulmonary Fibrosis | 12.3% | 12.1% | 14.3% | 15.7% | 16.4% | 20.0% | 18.2% | 12.0% | 14.5% | 15.6% |
| Alpha-1-Antitrypsin Deficiency | 7.2% | 6.5% | 6.5% | 6.2% | 6.1% | 5.6% | 4.6% | 7.0% | 5.6% | 5.3% |
| Primary Pulmonary Hypertension | 9.7% | 9.3% | 9.5% | 9.6% | 7.9% | 7.9% | 7.4% | 7.0% | 4.9% | 3.9% |
| Retransplant/Graft Failure | 2.3% | 2.5% | 2.2% | 2.6% | 2.5% | 2.3% | 3.0% | 2.4% | 4.2% | 3.3% |
| Congenital Disease | 2.2% | 1.9% | 2.3% | 2.4% | 2.2% | 1.5% | 1.2% | 1.2% | 1.5% | 0.8% |
| Other | 11.9% | 12.0% | 13.1% | 14.1% | 15.1% | 14.0% | 14.7% | 13.8% | 13.4% | 12.4% |
| Unknown | 2.6% | 2.2% | 1.2% | 1.3% | 1.6% | 1.8% | 4.1% | 5.8% | 4.8% | 5.9% |